Most people who reach out about medical weight loss have already tried hard. They’ve counted calories, joined gyms and followed plans that worked for a while and then stopped working. That pattern isn’t a failure of willpower. When you lose weight, your body pushes back: hunger hormones rise, fullness signals fade and your metabolism slows. Medications that work on those signals can make the effort you’re already putting in pay off.
What GLP-1 medications actually do
GLP-1 is a hormone your gut releases after you eat. It tells your brain you’re full, slows how quickly your stomach empties and helps your body release insulin when blood sugar rises. GLP-1 medications mimic that hormone, but they last much longer than the natural version.
- Semaglutide acts on the GLP-1 receptor. It’s taken as a once-weekly injection.
- Tirzepatide acts on two receptors, GLP-1 and GIP, another gut hormone involved in appetite and blood sugar. It’s also a once-weekly injection.
In practice, people describe feeling satisfied with smaller portions, thinking about food less often and finding it easier to stop eating when they’re full.
What results look like
In the large clinical trial that led to semaglutide’s approval for weight management, adults lost an average of about 15% of their body weight over 68 weeks, compared with about 2% on placebo. In the main tirzepatide trial, average weight loss over 72 weeks ranged from about 15% to 21%, depending on the dose. In both studies, participants also made diet and activity changes.
Averages hide a wide range. Some people lose more, some less, and a few don’t respond well. Many people also see improvements beyond the scale, such as lower blood pressure, better blood sugar and better cholesterol numbers.
Who may be a good candidate
For weight management, these medications are generally used for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea. Your clinician looks at your whole history, not just a number.
GLP-1 medications aren’t right for everyone. Be sure to mention:
- A personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN 2). People with this history shouldn’t take these medications.
- Past pancreatitis, gallbladder disease or serious digestive conditions, such as gastroparesis.
- Pregnancy, breastfeeding or plans to become pregnant.
- Diabetes medications such as insulin or sulfonylureas, which can raise the risk of low blood sugar when combined with a GLP-1.
- Birth control pills, if you’re considering tirzepatide. It can make them less effective for a while after starting and after each dose increase, so a backup method is recommended during those periods.
What the first months feel like
Treatment starts at a low dose that increases gradually, usually every four weeks, so your body can adjust. The most common side effects are nausea, fullness, constipation and diarrhea. They’re usually strongest after a dose increase and tend to ease over time.
A few habits help:
- Eat smaller meals, and stop as soon as you feel full.
- Go easy on greasy, fried or very rich foods.
- Drink plenty of water.
- Build meals around protein.
Some symptoms need prompt attention. Contact your clinician, or seek urgent care, for severe or persistent abdominal pain, vomiting you can’t keep fluids down through, or signs of dehydration.
Protecting muscle and planning for the long term
When you lose weight quickly, some of what you lose can be muscle. Eating enough protein and adding some strength training, even simple body-weight exercises a few times a week, helps you keep it.
It’s also worth talking about the long term from the start. Research shows that many people regain a significant share of the weight they lost within a year of stopping a GLP-1. That doesn’t mean you can never stop. It means stopping should be a plan you make with your clinician, not a surprise.
How it works at Fort Madison Med Spa
Every program starts with a telehealth visit by phone or video with Chris Castello, MSN, APRN, FNP-C. The visit covers your health history, current medications and goals, and includes labs. The initial consult with labs is $250*, and it’s waived with a 3-month prepay. If a GLP-1 isn’t a safe fit for you, we’ll tell you why.
If you’re eligible, semaglutide is $299* per month at any dose. Tirzepatide runs from $349* to $549* per month, depending on your dose tier. Follow-up visits to review progress, side effects and dose changes are included.
Questions to bring to your visit
- Which medication fits my history and goals, and why?
- What side effects should I watch for, and when should I call?
- How will we decide when to change my dose?
- What’s our plan if I want to stop someday?
*All pricing is subject to change at any time. This article is general information, not medical advice. Talk with a licensed clinician about your own situation.

